trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Osteosarcoma D012516 50 associated lipids
Brain Neoplasms D001932 15 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Melanoma D008545 69 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Asthma D001249 52 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Wilson DW et al. Defining the timing of action of antimalarial drugs against Plasmodium falciparum. 2013 Antimicrob. Agents Chemother. pmid:23318799
Ogura A et al. Recent advancements in cloning by somatic cell nuclear transfer. 2013 Philos. Trans. R. Soc. Lond., B, Biol. Sci. pmid:23166393
Dom G et al. 5-aza-2'-deoxycytidine has minor effects on differentiation in human thyroid cancer cell lines, but modulates genes that are involved in adaptation in vitro. 2013 Thyroid pmid:23167291
Soriano FX et al. SMRT-mediated co-shuttling enables export of class IIa HDACs independent of their CaM kinase phosphorylation sites. 2013 J. Neurochem. pmid:23083128
Tran L et al. Importance of epigenetic mechanisms in visceral pain induced by chronic water avoidance stress. 2013 Psychoneuroendocrinology pmid:23084728
Chen J et al. Prevention of cytotoxicity of nickel by quercetin: the role of reactive oxygen species and histone acetylation. 2013 Toxicol Ind Health pmid:22294440
Poplineau M et al. Epigenetically induced changes in nuclear textural patterns and gelatinase expression in human fibrosarcoma cells. 2013 Cell Prolif. pmid:23510467
Ding SZ et al. Epithelial-mesenchymal transition during oncogenic transformation induced by hexavalent chromium involves reactive oxygen species-dependent mechanism in lung epithelial cells. 2013 Toxicol. Appl. Pharmacol. pmid:23518002
Azechi T et al. Trichostatin A, an HDAC class I/II inhibitor, promotes Pi-induced vascular calcification via up-regulation of the expression of alkaline phosphatase. 2013 J. Atheroscler. Thromb. pmid:23518467
Duncan HF et al. Histone deacetylase inhibitors epigenetically promote reparative events in primary dental pulp cells. 2013 Exp. Cell Res. pmid:23562654
Wang Y et al. Role of histone deacetylase inhibitors in the aging of human umbilical cord mesenchymal stem cells. 2013 J. Cell. Biochem. pmid:23564418
Liu J et al. Direct differentiation of hepatic stem-like WB cells into insulin-producing cells using small molecules. 2013 Sci Rep pmid:23378917
Shah RR et al. Regulation of primitive hematopoiesis by class I histone deacetylases. 2013 Dev. Dyn. pmid:23184530
Gao SM et al. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms. 2013 Exp. Hematol. pmid:23111066
Liu RF et al. Down-regulation of miR-517a and miR-517c promotes proliferation of hepatocellular carcinoma cells via targeting Pyk2. 2013 Cancer Lett. pmid:23142219
Jang SM et al. Transcription factor Sox4 is required for PUMA-mediated apoptosis induced by histone deacetylase inhibitor, TSA. 2013 Biochem. Biophys. Res. Commun. pmid:23916609
Liu YQ et al. Identification of a novel human testicular interstitial gene, RNF148, and its expression regulated by histone deacetylases. 2013 Genet. Mol. Res. pmid:24089095
Florea AM DNA methylation pyrosequencing assay is applicable for the assessment of epigenetic active environmental or clinical relevant chemicals. 2013 Biomed Res Int pmid:24093099
Liu S et al. Up-regulation of miR-182 expression after epigenetic modulation of human melanoma cells. 2013 Ann. Surg. Oncol. pmid:22752337
Ononye SN et al. Tropolones as lead-like natural products: the development of potent and selective histone deacetylase inhibitors. 2013 ACS Med Chem Lett pmid:24900743
Feng L et al. Histone deacetylase 3 inhibits expression of PUMA in gastric cancer cells. 2013 J. Mol. Med. pmid:22763818
Kadiyala V et al. Class I lysine deacetylases facilitate glucocorticoid-induced transcription. 2013 J. Biol. Chem. pmid:23946490
Jung AR et al. Increased alternative lengthening of telomere phenotypes of telomerase-negative immortal cells upon trichostatin--a treatment. 2013 Anticancer Res. pmid:23482750
Piazza R et al. Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex. 2013 Neoplasia pmid:23633923
Hudson RS et al. Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 2013 Mol. Cancer pmid:23409773
Camolotto SA et al. PSG gene expression is up-regulated by lysine acetylation involving histone and nonhistone proteins. 2013 PLoS ONE pmid:23418492
Zutz C et al. Small chemical chromatin effectors alter secondary metabolite production in Aspergillus clavatus. 2013 Toxins (Basel) pmid:24105402
Viñuelas J et al. Quantifying the contribution of chromatin dynamics to stochastic gene expression reveals long, locus-dependent periods between transcriptional bursts. 2013 BMC Biol. pmid:23442824
Kim TW et al. Nuclear-encoded mitochondrial MTO1 and MRPL41 are regulated in an opposite epigenetic mode based on estrogen receptor status in breast cancer. 2013 BMC Cancer pmid:24160266
Chachadi VB et al. Prostatic cell-specific regulation of the synthesis of MUC1-associated sialyl Lewis a. 2013 PLoS ONE pmid:23451223
Kim YJ et al. HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade. 2013 Oncogene pmid:23435418
Moreaux J et al. Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors. 2013 Br. J. Cancer pmid:23868005
Yeo M et al. Bisphenol A delays the perinatal chloride shift in cortical neurons by epigenetic effects on the Kcc2 promoter. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23440186
Matsushita Y et al. HDAC inhibitors restore C-fibre sensitivity in experimental neuropathic pain model. 2013 Br. J. Pharmacol. pmid:24032674
Singh RK et al. Kinetic and thermodynamic rationale for suberoylanilide hydroxamic acid being a preferential human histone deacetylase 8 inhibitor as compared to the structurally similar ligand, trichostatin a. 2013 Biochemistry pmid:24079912
Day JA and Cohen SM Investigating the selectivity of metalloenzyme inhibitors. 2013 J. Med. Chem. pmid:24074025
Xia X et al. Effects of trichostatin A in a rat model of acute graft-versus-host disease after liver transplantation. 2013 Transplantation pmid:23694951
Fan J et al. Inhibition of HDAC2 protects the retina from ischemic injury. 2013 Invest. Ophthalmol. Vis. Sci. pmid:23696608
Li M et al. Upregulation of Toll-like receptor 2 gene expression by acetylation of AP-2 alpha in THP-1 cells, a human monocytic cell line. 2013 Int. J. Biochem. Cell Biol. pmid:23680675
Zhang Z et al. Stemness and inducing differentiation of small cell lung cancer NCI-H446 cells. 2013 Cell Death Dis pmid:23681228
Kannan V et al. Histone deacetylase inhibitors suppress immune activation in primary mouse microglia. 2013 J. Neurosci. Res. pmid:23686642
Oleksiewicz U et al. Cytoglobin has bimodal: tumour suppressor and oncogene functions in lung cancer cell lines. 2013 Hum. Mol. Genet. pmid:23591990
Breuzard G et al. Molecular mechanisms of Tau binding to microtubules and its role in microtubule dynamics in live cells. 2013 J. Cell. Sci. pmid:23659998
Theisen JW et al. Biochemical analysis of histone deacetylase-independent transcriptional repression by MeCP2. 2013 J. Biol. Chem. pmid:23349465
Nunes MJ et al. Histone deacetylase inhibition decreases cholesterol levels in neuronal cells by modulating key genes in cholesterol synthesis, uptake and efflux. 2013 PLoS ONE pmid:23326422
Murko C et al. Histone deacetylase inhibitor Trichostatin A induces neural tube defects and promotes neural crest specification in the chicken neural tube. 2013 Differentiation pmid:23328540
Algamas-Dimantov A et al. Epigenetic control of HNF-4α in colon carcinoma cells affects MUC4 expression and malignancy. 2013 Cell Oncol (Dordr) pmid:23307400
Johnson D and Walmsley R Histone-deacetylase inhibitors produce positive results in the GADD45a-GFP GreenScreen HC assay. 2013 Mutat. Res. pmid:23340162
Zhou G et al. HSV carrying WT REST establishes latency but reactivates only if the synthesis of REST is suppressed. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23341636
Chan ST et al. Quercetin enhances the antitumor activity of trichostatin A through upregulation of p53 protein expression in vitro and in vivo. 2013 PLoS ONE pmid:23342112